Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

41.88
+1.844.60%
Volume:311.05K
Turnover:12.84M
Market Cap:4.03B
PE:-21.41
High:42.00
Open:40.51
Low:40.06
Close:40.04
52wk High:42.00
52wk Low:23.23
Shares:96.27M
Float Shares:94.37M
Volume Ratio:0.80
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.36
PE(LYR):-32.59

Loading ...

IDEAYA Biosciences to present at Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 26

IDEAYA Biosciences (IDYA) Receives a Buy from LifeSci Capital

TIPRANKS
·
May 10

Some Analysts Just Cut Their IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Estimates

Simply Wall St.
·
May 07

RBC Capital Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)

TIPRANKS
·
May 06

IDEAYA Biosciences Files New Shelf Registration Statement

TIPRANKS
·
May 06

BRIEF-Ideaya Biosciences Inc - Enters Sales Agreement With Jefferies For Common Stock Offering Up To $350 Million - SEC Filing

Reuters
·
May 06

BRIEF-Ideaya Biosciences Inc Files For Mixed Shelf Offering, Size Not Disclosed- SEC Filing

Reuters
·
May 06

IDEAYA files prospectus for up to $156.6 million remaining at-the-market share sales

Reuters
·
May 06

IDEAYA Biosciences Inc Files for Mixed Shelf Offering, Size Not Disclosed- SEC Filing

THOMSON REUTERS
·
May 06

Analysts Are Bullish on Top Healthcare Stocks: Lineage Therap (LCTX), IDEAYA Biosciences (IDYA)

TIPRANKS
·
May 06

Ideaya Biosciences' Darovasertib Combination Data Profile is 'Highly Compelling,' Wedbush Says

MT Newswires Live
·
May 06

IDEAYA Biosciences Q1 EPS $(1.11) Misses $(0.98) Estimate, Sales $6.560M Beat $5.008M Estimate

Benzinga Earnings
·
May 05

IDEAYA Biosciences Q1 net loss widens, misses expectations on higher R&D spends

Reuters
·
May 05

Earnings Flash (IDYA) IDEAYA Biosciences Posts Q1 Loss $1.11 a Share, vs. FactSet Est of $1.05 Loss

MT Newswires Live
·
May 05

IDEAYA Q1 FY26 net loss widens to $98.5 million; revenue falls to $6.6 million

Reuters
·
May 05

IDEAYA Biosciences Inc - Reports ~$973 Mln Cash and Securities as of March 31, 2026; Cash Runway Into 2030 Unchanged

THOMSON REUTERS
·
May 05

IDEAYA Biosciences Inc - to Initiate Rtor Submission in May; Nda Filing Targeted for H2 2026

THOMSON REUTERS
·
May 05

IDEAYA Biosciences Q1 Collaboration Revenue USD 6.56 Million

THOMSON REUTERS
·
May 05

IDEAYA Biosciences Inc - Clinical Updates From Multiple Trials Planned for H2 2026

THOMSON REUTERS
·
May 05

IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 05